The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.25
Bid: 16.00
Ask: 16.50
Change: -0.75 (-4.41%)
Spread: 0.50 (3.125%)
Open: 17.00
High: 17.00
Low: 16.25
Prev. Close: 17.00
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EARNINGS SUMMARY: Novacyt Profit Leaps On Covid-19 Test Kit Demand

Thu, 17th Sep 2020 15:39

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Novacyt SA - Surrey-based biotechnology company making Covid-19 test kits - Revenue for six months to June 30 rockets to EUR72.4 million from EUR7.2 million, with Primerdesign revenue multiplying to EUR70.6 million from EUR3.3 million due to the success of the Covid-19 product portfolio. Margins increase to 83% from 63%. Swings to pretax profit of EUR46.1 million from a EUR1.2 million loss due to revenue surge. First half earnings before interest, tax, depreciation and amortisation surge to EUR49.4 million from EUR153,000. Revenue for the second half to be greater than the first half of the year and margins to be at least at a similar level. Full year revenue expected to exceed EUR150 million and Ebitda to exceed EUR100 million. Cash at June 30 of EUR19.7 million after paying down all long-term debt and significant working capital investment made into stock to ensure the continuity of supply to meet the demand for Covid-19 tests. Shares up 5.0% at 388.50 pence.

----------

ThinkSmart Ltd - Australian digital payments platform business - Pretax profit for year ended June 30 multiplies to GBP53.1 million from GBP524,000, driven by GBP53.7 million fair value gain on revaluation of the retained shareholding in Clearpay Finance Ltd. Revenue falls year-on-year to GBP6.1 million from GBP7.2 million. Continues to manage the wind down of legacy business. Cash and cash equivalents of GBP8.8 million at June 30. Shares up 17% at 44.00 pence.

----------

Supermarket Income REIT PLC - UK-focused supermarket income trust - To raise GBP150 million by way of a placing and subscription of shares at 104 pence each, a 6.3% discount to Wednesday's closing stock price of 111p. Current stock price 109.00p, down 1.8%. Proceeds to fund investment opportunities which are currently in excess of GBP400 million. EPRA net asset value per share for the 12 months to June 30 rises 4% to 101p. Passing rent up 49% at GBP28.7 million. 100% of all rents collected in full. Annual dividend up 3.8% at 5.8p. Increases dividend target for financial 2021 to 5.86p.

----------

Aberdeen Smaller Companies Income Trust PLC - investment trust focused on smaller UK companies - Net asset value total return for six months to June 30 minus 16.9% versus minus 25.0% return from Numis Small Companies excluding Investment Trust index. Net asset value per share 306.14p at June 30, down 18% from 373.86p at December 31. Attributes negative return to Covid-19 pandemic. Stock down 0.8% at 262.00 pence.

----------

DX Group PLC - Slough-based courier and logistics services - Revenue for year ended June 27 rises 2.1% to GBP329.3 million from GBP322.5 million. Pretax loss narrows to GBP1.3 million from GBP1.7 million. Revenue fell by a third immediately post-lockdown, but volumes steadily recovered from April and are now above levels anticipated pre-lockdown. Trading in the first months of financial 2020 ahead of the same period last year. Healthy pipeline of new business opportunities. Sees opportunity to increase volumes and further expand margins. Net cash of GBP12.3 million at June 27, better than expected. Shares down 11% at 17.15 pence.

----------

Destiny Pharma PLC - Brighton-based biotechnology company - Pretax loss for the six months to June 30 widens year-on-year to GBP2.9 million from GBP2.4 million. No revenue generated as the company is still in clinical stage of developing products. Research and development costs rise to GBP2.3 million from GBP1.7 million. Funded through fourth-quarter of 2021. Strong cash position with cash and term deposits of GBP5.6 million at June 30. Stock up 3.5% at 60.00 pence.

----------

GCP Student Living PLC - UK-focused student accommodation provider - EPRA net asset value per share for year to June 30 171.78 pence, up from 165.52p a year ago. Property portfolio value rises to GBP1.00 billion from GBP921.6 million. Student rental growth 4.4% versus 3.5%. Rental income rises year-on-year to GBP47.8 million from GBP44.4 million. Chair Robert Peto to retire at 2020 annual general meeting. Annual dividend unchanged at 6.15p. Shares up 2.2% at 139.00p.

----------

Enwell Energy PLC - Ukraine-focused oil and gas explorer - Revenue for six months to June 30 falls 21% year-on-year to USD24.7 million as a result of weakened gas prices in the period. Pretax profit falls 80% to USD2.6 million from USD13.3 million. Average daily production from the MEX-GOL, SV and VAS fields of 4,545 barrels of oil equivalent per day, down 8% from 4,192 barrels. Cash and cash equivalents of USD54.2 million at June 30 and USD55.5 million at September 13. Shares down 2.5% at 15.13 pence.

----------

Gresham House PLC - London-based asset manager - Assets under management rises 17% in the six months to June 30 to GBP3.26 billion from GBP2.80 billion at December 31, helped by 10% organic growth. Core income up 33% to GBP17.8 million. Pretax loss widens year-on-year to GBP1.6 million from GBP801,000. Well placed for the second half of 2020 and beyond. Strong balance sheet with cash and liquid assets at GBP45.1 million and zero debt. Shares up 5.0% at 724.80 pence.

----------

Regional REIT Ltd - UK-focused real estate investment trust - EPRA net asset value per share falls to 102.6 pence at June 30 from 112.7p at December 31. Resilient rental and property income in six months to June-end of GBP29.4 million versus GBP29.9 million. Rent collection strong with 97.6% of the rent invoiced for the period to June 30 being collected as at September 11. EPRA occupancy rate stable at 89.0%. Cuts first half dividend to 3.4p from 3.8p. Targeting an expected full year dividend of 6.4p. Cash and cash equivalent GBP67.9 million. Shares up 2.8% at 68.89p.

----------

Zephyr Energy PLC - technology-led oil and gas exploration company focused on US - Swings to a pretax profit of USD906,000 for the six months to June 30 from USD826,000 loss due to foreign exchange gains of USD1.6 million versus USD126,000 loss. No revenue generated in either financial periods. Administrative costs fall year-on-year to USD613,000 from USD806,000. Shares down 2.6% at 0.76 pence.

----------

Wilmington PLC - London-based data and information services company - Results for 12 months to June 30 at the top end of range previously provided for both revenue and profit. Revenue for the year down 8% to GBP113.1 million, hurt by no face-to-face events or training in final quarter. Pretax profit down 56% at GBP6.4 million due to Covid-19 impact and absence of disposal gains. Net debt improves to GBP27.7 million at June 30 from GBP33.9 million a year ago. Dividend suspended but remains committed to a resumption of dividends as soon as the trading environment normalises. Profitable in the first two months of financial 2021. Shares down 0.4% at 130.00 pence.

----------

Velocys PLC - Oxford, England-based fuels technology company - Revenue multiplies to GBP180,000 for six months ended June 30 from GBP22,000 a year ago. Pretax loss narrows to GBP2.7 million from GBP4.7 million. Sees significant uplift in demand for sustainable fuels. Cash at period end of GBP816,000 versus GBP4.8 million at December 31. Shares up 2.8% at 6.80p.

----------

SolGold PLC - Australian gold and copper mining company - Pretax loss for the year to June 30 narrows year-on-year to USD13.0 million from USD32.7 million due to a sharp drop in share based payment expenses to USD1.2 million from USD23.9 million. No revenue generated in either financial period. Administrative expenses rise to USD12.4 million from USD9.2 million. Shares down 1.5% at 26.99 pence.

----------

DP Aircraft I Ltd - Guernsey-based aircraft leasing company - Net asset value per share plummets to USD0.6502 for the six months to June 30 from USD1.0304 at December 31. Lease rental income for the first half falls to USD24.4 million from USD28.6 million. Swings to pretax loss of USD72 million from USD11.7 million. Books USD71.2 million impairment against aircraft assets and USD15.7 million against the lease premium, in light of Covid-19 pandemic. Prioritising the preservation of long-term financial stability. Available cash projected at the end of September of USD3 million. Stock up 0.1% at USD0.090.

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 20:57

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Apr 2024 10:23

AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
31 Jan 2024 18:28

EARNINGS AND TRADING: STV raises holding in Two Cities Television

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
4 Jan 2024 14:07

Destiny Pharma seeks to capitalise on XF-73 market potential in 2024

(Alliance News) - Destiny Pharma PLC on Thursday said that its priority remains promoting its XF-73 Nasal antibacterial drug.

Read more
4 Jan 2024 11:27

Destiny Pharma reports progress on clinical assets

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said in a year-end update on Thursday that its primary focus remained on realising the full potential of its XF-73 Nasal asset.

Read more
29 Oct 2023 21:01

Sunday share tips: Destiny Pharma, Invinity Energy Systems

(Sharecast News) - The Financial Mail on Sunday's Midas column spied long-term potential in Destiny Pharma's shares.

Read more
17 Oct 2023 11:15

Destiny Pharma celebrates study findings on "potent" flagship drug

(Alliance News) - Destiny Pharma PLC shares soared on Tuesday after new data showed XF-73, its leading antibacterial drug, to be effective against over 2,500 Staphylococcus isolates, including resistant strains.

Read more
17 Oct 2023 10:18

AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
20 Sep 2023 14:27

TRADING UPDATES: Dianomi swings to loss; Epwin revenue up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Sep 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
Tuesday 19 September 
accesso Technology Group PLCHalf Year Results
Billington Holdings PLCHalf Year Results
Big Technologies PLCHalf Year Results
C&C Group PLCTrading Statement
Concurrent Technologies PLCHalf Year Results
CPPGroup PLCHalf Year Results
Eagle Eye Solutions Group PLCFull Year Results
Fintel PLCHalf Year Results
Good Energy Group PLCHalf Year Results
Hargreaves Lansdown PLCFull Year Results
Henry Boot PLCHalf Year Results
Kingfisher PLCHalf Year Results
Litigation Capital Management LtdFull Year Results
Maintel Holdings PLCHalf Year Results
McBride PLCFull Year Results
MyHealthChecked PLCHalf Year Results
Moonpig Group PLCTrading Statement
Naked Wines PLCFull Year Results
Northcoders Group PLCHalf Year Results
Ocado Group PLCTrading Statement
Serica Energy PLCHalf Year Results
SThree PLCTrading Statement
Surgical Innovations Group PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
Water Intelligence PLCHalf Year Results
Xaar PLCHalf Year Results
Wednesday 20 September 
Advanced Medical Solutions Group PLCHalf Year Results
ASA International Group PLCHalf Year Results
Destiny Pharma PLCHalf Year Results
Dunelm Group PLCTrading Statement
Epwin Group PLCHalf Year Results
Galliford Try Holdings PLCFull Year Results
GENinCode PLCHalf Year Results
HydrogenOne Capital Growth PLCHalf Year Results
Judges Scientific PLCHalf Year Results
LBG Media PLCHalf Year Results
M&G PLCHalf Year Results
Oxford Biomedica PLCHalf Year Results
PYX Resources LtdHalf Year Results
Round Hill Music Royalty Fund LtdHalf Year Results
Supermarket Income REIT PLCFull Year Results
Ten Entertainment Group PLCHalf Year Results
Warpaint London PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 Jul 2023 17:31

TRADING UPDATES: MGC Pharmaceuticals granted psilocybin import permit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
25 Jul 2023 14:27

IN BRIEF: Destiny Pharma says former Chair Nigel Rudd return to role

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Says Nigel Rudd will be returning as chair, effective immediately. He was chair of Destiny from 2010 to 2018, and led its flotation on the London AIM market.

Read more
19 Jul 2023 13:16

IN BRIEF: Destiny Pharma appoints Chris Tovey as CEO; Chair resigns

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Appoints Chris Tovey as chief executive officer from September 1, taking over from Interim CEO Debra Barker who will return to position of non-executive director. The company announces departure of Chair Nick Rodgers, expects to announce new outside chair shortly.

Read more
6 Jul 2023 12:49

IN BRIEF: Destiny Pharma confirms phase 3 development for lead asset

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Confirms proposed phase three development pathway and identifies new life cycle management targets for its XF-73 Nasal programme. Says antimicrobial properties of XF-73 Nasal give greater flexibility in the scheduling of surgeries. Adds there is potential to explore new life management indications, particularly in children.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.